nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinalukast—CYSLTR1—uterus—breast cancer	0.0372	0.17	CbGeAlD
Cinalukast—CYSLTR1—adipose tissue—breast cancer	0.0363	0.166	CbGeAlD
Cinalukast—CYSLTR1—female reproductive system—breast cancer	0.0334	0.153	CbGeAlD
Cinalukast—CYSLTR1—adrenal gland—breast cancer	0.0326	0.149	CbGeAlD
Cinalukast—CYSLTR1—bone marrow—breast cancer	0.0315	0.144	CbGeAlD
Cinalukast—CYSLTR1—endocrine gland—breast cancer	0.0283	0.129	CbGeAlD
Cinalukast—CYSLTR1—lymph node—breast cancer	0.0195	0.0893	CbGeAlD
Cinalukast—CYSLTR1—Endothelins—MAPK8—breast cancer	0.00493	0.00631	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—SRC—breast cancer	0.00467	0.00598	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—ITPR1—breast cancer	0.00459	0.00588	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—breast cancer	0.00458	0.00586	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—breast cancer	0.00441	0.00564	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—breast cancer	0.00441	0.00564	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CCL20—breast cancer	0.00438	0.00561	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—CXCR4—breast cancer	0.00438	0.0056	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—GPER1—breast cancer	0.00431	0.00552	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—MAPK3—breast cancer	0.0043	0.00551	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—LPAR1—breast cancer	0.00424	0.00543	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—breast cancer	0.00422	0.0054	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STARD8—breast cancer	0.00422	0.0054	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—NMBR—breast cancer	0.00413	0.00529	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—breast cancer	0.00411	0.00526	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—breast cancer	0.00408	0.00522	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCRs, Class A Rhodopsin-like—AGTR1—breast cancer	0.00396	0.00507	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—GPER1—breast cancer	0.00391	0.00501	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CNR2—breast cancer	0.0039	0.005	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PTGER1—breast cancer	0.00384	0.00492	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—NMBR—breast cancer	0.00375	0.0048	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—breast cancer	0.00375	0.0048	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—breast cancer	0.00375	0.0048	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—WNT1—breast cancer	0.00367	0.0047	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PTGER1—breast cancer	0.00349	0.00447	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL3—breast cancer	0.00342	0.00438	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CCL27—breast cancer	0.00342	0.00438	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PDE2A—breast cancer	0.00342	0.00438	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—breast cancer	0.00339	0.00434	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—AGTR2—breast cancer	0.00336	0.0043	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL2—breast cancer	0.00336	0.0043	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—PTHLH—breast cancer	0.00332	0.00425	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—HRAS—breast cancer	0.00329	0.00421	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—EDNRB—breast cancer	0.00322	0.00412	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—WNT10B—breast cancer	0.00319	0.00408	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCL27—breast cancer	0.00311	0.00398	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL3—breast cancer	0.00311	0.00398	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PDE2A—breast cancer	0.00311	0.00398	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CALCA—breast cancer	0.00292	0.00374	CbGpPWpGaD
Cinalukast—CYSLTR1—Endothelins—AKT1—breast cancer	0.0029	0.00372	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCR4—breast cancer	0.00285	0.00365	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL12—breast cancer	0.00285	0.00365	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—AGTR1—breast cancer	0.00258	0.0033	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—RGS2—breast cancer	0.0025	0.0032	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CCL20—breast cancer	0.00248	0.00317	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCDC88C—breast cancer	0.00242	0.0031	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LGR6—breast cancer	0.00242	0.0031	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—LPAR1—breast cancer	0.0024	0.00307	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SFRP1—breast cancer	0.00231	0.00296	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GPER1—breast cancer	0.00231	0.00296	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RGS2—breast cancer	0.00227	0.00291	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PDE4D—breast cancer	0.00226	0.0029	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CCL20—breast cancer	0.00225	0.00288	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—breast cancer	0.00224	0.00286	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NMBR—breast cancer	0.00222	0.00284	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CNR2—breast cancer	0.00221	0.00282	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—LPAR1—breast cancer	0.00218	0.00279	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PTGER1—breast cancer	0.00206	0.00264	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CUL5—breast cancer	0.00206	0.00264	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HEYL—breast cancer	0.00206	0.00264	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PDE4D—breast cancer	0.00206	0.00263	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CNR2—breast cancer	0.002	0.00256	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RSPO3—breast cancer	0.00194	0.00248	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AGTR2—breast cancer	0.0019	0.00243	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL2—breast cancer	0.0019	0.00243	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—WNT10B—breast cancer	0.00188	0.00241	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—WWOX—breast cancer	0.00188	0.00241	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—WNT1—breast cancer	0.00188	0.00241	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PTHLH—breast cancer	0.00188	0.0024	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCL27—breast cancer	0.00184	0.00235	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDE2A—breast cancer	0.00184	0.00235	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—INHBB—breast cancer	0.00184	0.00235	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL3—breast cancer	0.00184	0.00235	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—EDNRB—breast cancer	0.00182	0.00233	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—DLL4—breast cancer	0.00175	0.00224	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BMPR2—breast cancer	0.00175	0.00224	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AGTR2—breast cancer	0.00172	0.00221	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL2—breast cancer	0.00172	0.00221	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PTHLH—breast cancer	0.0017	0.00218	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDH5—breast cancer	0.00168	0.00215	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CALCA—breast cancer	0.00165	0.00211	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EDNRB—breast cancer	0.00165	0.00211	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SFRP2—breast cancer	0.00165	0.00211	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRLR—breast cancer	0.00162	0.00207	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL12—breast cancer	0.00161	0.00207	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCR4—breast cancer	0.00161	0.00207	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—breast cancer	0.00161	0.00206	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GLI2—breast cancer	0.00156	0.002	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VCP—breast cancer	0.00156	0.002	CbGpPWpGaD
Cinalukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	0.00155	0.00199	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LEPR—breast cancer	0.00154	0.00197	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—breast cancer	0.00153	0.00196	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CALCA—breast cancer	0.0015	0.00192	CbGpPWpGaD
Cinalukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—breast cancer	0.00149	0.0019	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCR4—breast cancer	0.00147	0.00188	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL12—breast cancer	0.00147	0.00188	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AGTR1—breast cancer	0.00146	0.00187	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—breast cancer	0.00145	0.00185	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ARHGDIA—breast cancer	0.00143	0.00183	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FST—breast cancer	0.00139	0.00178	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HEY2—breast cancer	0.00138	0.00176	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RPS6KB2—breast cancer	0.00136	0.00174	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RGS2—breast cancer	0.00134	0.00172	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—breast cancer	0.00133	0.0017	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCL20—breast cancer	0.00133	0.0017	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AGTR1—breast cancer	0.00132	0.0017	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—ITPR1—breast cancer	0.00131	0.00168	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TLE3—breast cancer	0.00129	0.00165	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LPAR1—breast cancer	0.00129	0.00165	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HEY1—breast cancer	0.00127	0.00163	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—DLL1—breast cancer	0.00125	0.0016	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—breast cancer	0.00123	0.00158	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIST1H2BK—breast cancer	0.00123	0.00157	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIST1H2BC—breast cancer	0.00123	0.00157	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDE4D—breast cancer	0.00121	0.00155	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GRB7—breast cancer	0.00121	0.00155	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CSF2—breast cancer	0.00121	0.00155	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TAB2—breast cancer	0.00119	0.00153	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—ITPR1—breast cancer	0.00119	0.00152	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CNR2—breast cancer	0.00118	0.00152	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR ligand binding—CXCL8—breast cancer	0.00118	0.00151	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MMP3—breast cancer	0.00118	0.00151	CbGpPWpGaD
Cinalukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—breast cancer	0.00118	0.00151	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—DKK1—breast cancer	0.00116	0.00148	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VEGFC—breast cancer	0.00115	0.00147	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—JAG2—breast cancer	0.00113	0.00145	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—WNT1—breast cancer	0.00111	0.00142	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PLA2G4A—breast cancer	0.00111	0.00142	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CSF2—breast cancer	0.0011	0.00141	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOTCH4—breast cancer	0.00105	0.00135	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—GZMB—breast cancer	0.00105	0.00134	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL2—breast cancer	0.00102	0.0013	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AGTR2—breast cancer	0.00102	0.0013	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BMP2—breast cancer	0.00101	0.00129	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PTHLH—breast cancer	0.00101	0.00129	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EDNRB—breast cancer	0.000975	0.00125	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PGR—breast cancer	0.000965	0.00124	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—THBS1—breast cancer	0.00096	0.00123	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FLT1—breast cancer	0.000916	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF3—breast cancer	0.000912	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SQSTM1—breast cancer	0.000912	0.00117	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CG—breast cancer	0.000908	0.00116	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—JAG1—breast cancer	0.000901	0.00115	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOTCH3—breast cancer	0.000897	0.00115	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PARP1—breast cancer	0.000897	0.00115	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CALCA—breast cancer	0.000886	0.00113	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RPS6—breast cancer	0.000876	0.00112	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF4—breast cancer	0.000869	0.00111	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL12—breast cancer	0.000865	0.00111	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCR4—breast cancer	0.000865	0.00111	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PAK1—breast cancer	0.000849	0.00109	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TCF7L2—breast cancer	0.000835	0.00107	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AKT2—breast cancer	0.000831	0.00106	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CG—breast cancer	0.000824	0.00106	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HSP90AA1—breast cancer	0.000805	0.00103	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOTCH2—breast cancer	0.000805	0.00103	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CD—breast cancer	0.000798	0.00102	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PRL—breast cancer	0.000783	0.001	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AGTR1—breast cancer	0.000783	0.001	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STK11—breast cancer	0.000771	0.000987	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ADAM10—breast cancer	0.000771	0.000987	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLG—breast cancer	0.000763	0.000976	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AKT2—breast cancer	0.000754	0.000966	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF10—breast cancer	0.00075	0.000961	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CD—breast cancer	0.000725	0.000928	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PDGFA—breast cancer	0.000724	0.000927	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TGFBR2—breast cancer	0.000714	0.000914	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ITPR1—breast cancer	0.000702	0.000899	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STAT5A—breast cancer	0.000698	0.000893	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MMP3—breast cancer	0.000698	0.000893	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB4—breast cancer	0.000698	0.000893	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CB—breast cancer	0.000696	0.00089	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SMAD4—breast cancer	0.000676	0.000865	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF1R—breast cancer	0.000671	0.00086	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—CXCL8—breast cancer	0.000668	0.000856	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HES1—breast cancer	0.00066	0.000844	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NCOR1—breast cancer	0.000656	0.00084	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PLA2G4A—breast cancer	0.000656	0.00084	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGF1—breast cancer	0.000649	0.00083	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CSF2—breast cancer	0.000649	0.00083	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—RAF1—breast cancer	0.000647	0.000828	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NRG1—breast cancer	0.000644	0.000824	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—H2AFX—breast cancer	0.000639	0.000818	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—IL2—breast cancer	0.000639	0.000818	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—E2F1—breast cancer	0.000635	0.000812	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CB—breast cancer	0.000632	0.000809	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SPP1—breast cancer	0.00061	0.000781	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—CXCL8—breast cancer	0.000607	0.000777	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB3—breast cancer	0.000603	0.000772	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGFR2—breast cancer	0.000602	0.000771	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL2—breast cancer	0.00058	0.000743	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TERT—breast cancer	0.000578	0.00074	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FGFR1—breast cancer	0.000561	0.000718	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HIF1A—breast cancer	0.000553	0.000708	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—LEP—breast cancer	0.00054	0.000691	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CAV1—breast cancer	0.000535	0.000684	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KDR—breast cancer	0.000529	0.000677	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ESR1—breast cancer	0.000515	0.00066	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—FN1—breast cancer	0.000509	0.000651	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NFKBIA—breast cancer	0.000503	0.000644	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOTCH1—breast cancer	0.000498	0.000638	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CG—breast cancer	0.000487	0.000623	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KIT—breast cancer	0.000487	0.000623	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—APC—breast cancer	0.000487	0.000623	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EGF—breast cancer	0.000481	0.000616	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—MAPK3—breast cancer	0.000466	0.000597	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—BRAF—breast cancer	0.000458	0.000586	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IGF1—breast cancer	0.000446	0.000571	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKT2—breast cancer	0.000446	0.00057	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—EGFR—breast cancer	0.000444	0.000568	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CD—breast cancer	0.000428	0.000548	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—PIK3CA—breast cancer	0.000424	0.000543	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SERPINE1—breast cancer	0.000423	0.000542	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—KRAS—breast cancer	0.000419	0.000537	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—NOS3—breast cancer	0.000404	0.000518	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—PIK3CA—breast cancer	0.000385	0.000493	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MDM2—breast cancer	0.000384	0.000491	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RAF1—breast cancer	0.000382	0.000489	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—RELA—breast cancer	0.000381	0.000487	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—ERBB2—breast cancer	0.000378	0.000484	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MTOR—breast cancer	0.000373	0.000478	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CB—breast cancer	0.000373	0.000478	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CXCL8—breast cancer	0.000359	0.000459	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—HRAS—breast cancer	0.000356	0.000456	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN1B—breast cancer	0.00035	0.000448	CbGpPWpGaD
Cinalukast—CYSLTR1—GPCR downstream signaling—AKT1—breast cancer	0.000346	0.000443	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CASP3—breast cancer	0.000343	0.000439	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL2—breast cancer	0.000343	0.000439	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—IL6—breast cancer	0.000341	0.000437	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CCND1—breast cancer	0.000334	0.000428	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—JUN—breast cancer	0.000333	0.000427	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CTNNB1—breast cancer	0.000331	0.000424	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MMP9—breast cancer	0.000324	0.000415	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—CDKN1A—breast cancer	0.000323	0.000414	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PTEN—breast cancer	0.000322	0.000413	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAPK8—breast cancer	0.000315	0.000404	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling by GPCR—AKT1—breast cancer	0.000315	0.000403	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—SRC—breast cancer	0.000299	0.000383	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—VEGFA—breast cancer	0.000291	0.000373	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—STAT3—breast cancer	0.000288	0.000369	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MAPK3—breast cancer	0.000276	0.000353	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—MYC—breast cancer	0.000268	0.000343	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TGFB1—breast cancer	0.000267	0.000342	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—EGFR—breast cancer	0.000262	0.000336	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—KRAS—breast cancer	0.000248	0.000317	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—PIK3CA—breast cancer	0.000227	0.000291	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—TP53—breast cancer	0.00022	0.000282	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—HRAS—breast cancer	0.00021	0.000269	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—IL6—breast cancer	0.000201	0.000258	CbGpPWpGaD
Cinalukast—CYSLTR1—Signaling Pathways—AKT1—breast cancer	0.000186	0.000238	CbGpPWpGaD
